| Portfolio Companies To view the
investment structure, please click here >>
BioVittoria
Limited Derceto has headquarters in Auckland and San Francisco. Derceto
has the first in market "customized off-the-shelf" (COTS)
software tool which works online and in real-time to reduce the
costs of treated water distribution. Derceto optimizes pump schedules
to minimize distribution costs guided primarily by electricity tariffs.
Derceto is jointly owned by the Beca Group, Endeavour Capital and
key staff. Doctor
Global Limited (Investment by Endeavour Capital) Ectus Ltd Ectus technology has application in Education, Health, Government
and Commerce.
GeoSmart GFG
Group Accredited by the World Bank, GFG is acknowledged as a leader
in its field. HTS-110 Nexus6 Limited A peak flow meter also fitted with a microcomputer measures the
patient’s lunch function. All the data is then fed into a
software programme that summarises the results. Smartinhaler®
also has an alarm to remind users to take their medication. The
Smartinhaler® has been shown in clinical trials to increase
an asthma user’s compliance. Pacific
Aerospace Corporation Our holding in Pacific Aerospace Corporation was sold in October 2006.
Proacta Therapeutics is a New Zealand based anti-cancer company (a cooperative venture between The University of Auckland and Stanford University). Proacta is undergoing toxicity and clinical studies with their lead compounds in solid tumour hypoxia. The founding scientists, Professors Bill Denny and Bill Wilson
at the Auckland Cancer Society Research Centre, at The University
of Auckland (ACSRC), and Professors Martin Brown and Amato Giacca
at the Division of Radiation and Cancer Biology and the Department
of Radiation Oncology at Stanford University are considered world
leading authorities in the field of tumour hypoxia, a condition
that exists in a majority of solid tumours and makes treatment with
conventional chemo and radiotherapy less likely to succeed. Protemix
Corporation Limited (Investment by both Endeavour Capital and Endeavour i-cap Fund) Simtrix SMX Veritide
Limited The first product will be a bacterial spore detector that enables
rapid determination of whether a white powder incident is a false
alarm or a potential anthrax threat. ZyGEM
Corporation Limited (Investment by Endeavour Capital) |
People
Head
office contact details Endeavour Capital For further contact details, click here >> |
Ectus
is a company commercialising collaborative learning, video conferencing
and streaming technologies. Ectus focuses on integrating synchronous
and asynchronous collaboration technology, the theory of online
communities, learning and best practice to provide interactive,
stimulating and supportive on-line working and learning environments.
Ectus works with clients to transform face to face processes to
create effective on-line communities. 
Nexus6
was founded in 2001 to commercialise technology for the Asthma market.
Their flagship product, Smartinhaler®, is an inhaler which is
fitted with a microcomputer that records every puff of medicine
a patient takes, including details such as the date and time it
was taken. 
